Navigation Links
Exelixis Announces Full Year and Fourth Quarter 2007 Financial Results
Date:2/14/2008

e moved several compounds into phase 2 development, continued to expand our clinical development pipeline and finished the year with approximately $300 million in cash," said George Scangos, Ph.D., president and chief executive officer of Exelixis, Inc. "The rapid advancement of our pipeline has positioned 2008 to be a transformative year for the company. We have submitted ten abstracts to ASCO covering a number of compounds and trials. Importantly, we hope to present meaningful data sets for XL647, XL880 and XL184, as well as our inhibitors of the PI3 kinase and MAP kinase pathways. We also plan to initiate pivotal trials this year for XL647 for non-small cell lung cancer, XL184 for medullary thyroid cancer, and potentially XL019 for myelofibrosis. We also expect multiple opt-in decisions in 2008 from partners that will give us the opportunity to co-develop and profit-share in new compounds targeting important pathways commonly deregulated in human cancers."

Financial Outlook

For the full year 2008, we expect revenues in the range of $100.0 million to $130.0 million and operating expenses in the range of $290.0 million to $320.0 million, including stock-based compensation and other non-cash charges of approximately $20.0 million to $25.0 million. The increase in expenses is primarily related to the ongoing advancement and expansion of our development activities and corresponding increases in our general and administrative infrastructure. The Company's cash, cash equivalents, short-term and long-term marketable securities, investments held by Symphony Evolution, Inc. and restricted cash balance at the end of 2008 is expected to exceed $200.0 million.

Conference Call and Webcast

Exelixis' management will discuss the company's full year and fourth quarter 2007 financial results as well as general business updates during a conference call beginning at 2:00 p.m. PT/ 5:00 p.m. ET today, Thursday, February 14, 2008. To listen to a webcast of th
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
2. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
3. Exelixis Announces January 31 Webcast of Presentation at the 2008 Wachovia Healthcare Conference
4. Exelixis Announces Senior Management Promotions
5. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
6. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
7. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
8. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
11. Exelixis Sells 80% Stake in Artemis to Taconic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... British Columbia , March 2, 2015 /PRNewswire/ ... a clinical stage biopharmaceutical company specializing in the ... Craig Schneider , Chief Executive Officer, will ... at VirtualInvestorConferences.com. DATE: Thursday, March 5, ... click the red "register/ watch event now" button ...
(Date:3/2/2015)... , March 2, 2015 ... to bottom.   Moments ago, Analysts Review ... Sunshine Heart (NASDAQ: SSH ), Synergetics ... Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... Analysts Review provides a single unified platform for investors, to ...
(Date:3/2/2015)... Kent, WA (PRWEB) March 02, 2015 ... tangential flow flat-sheet testing system at the 2015 AMTA ... is a culmination of a decade’s worth of engineering ... system compatible with a wide range of applications across ... be versatile enough to meet the dynamic needs of ...
(Date:3/1/2015)... Market Publishers Ltd and DataGroup Booksellers ... promotion on Internet. MarketPublishers.com is now authorised to ... DataGroup Booksellers. , Natalie Aster, Assistant Manager at ... the recent partnership agreement as follows: “We are ... of publishers. Since 1974, the company has been ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Sterlitech Displays Complete CF042 Membrane Test System 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3
... Rochelle, NY, February 8, 2011Successful intranasal delivery of ... Parkinson disease yielded significant improvement in motor function ... disease. These highly promising findings, reported in ... Mary Ann Liebert, Inc. highlight the potential for ...
... ST. LOUIS, Feb. 16, 2011 / PRNewswire/ ... announces the following executive leadership appointments intended to ... strategic plan. Frank Wicks, President Research, ... Research products, including those in Research Essentials, Research ...
... 16, 2011 Pneumococcus ( Streptococcus pneumoniae ) ... mortality in young children worldwide. While successful vaccines ... work against specific pneumococcal strains, with the risk ... Through a novel discovery approach, researchers at Children,s ...
Cached Biology Technology:Sigma-Aldrich Announces Organizational Changes 2Sigma-Aldrich Announces Organizational Changes 3New Pneumococcal Vaccine Approach Successful in Early Tests 2New Pneumococcal Vaccine Approach Successful in Early Tests 3New Pneumococcal Vaccine Approach Successful in Early Tests 4
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... POINT ROBERTS, Washington , January 20, 2015 ... technology and tech stocks, releases video from the CES 2015 ... security consultant Apollo Robbins . Apollo shows ... Wocket™ biometric smart wallet, a product of NXT-ID, Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Relatives of a young person who dies suddenly should ... order to identify if they too are at risk ... of the European Society of Human Genetics today (Tuesday ... a research fellow at the Department of Cardiogenetics, Academic ...
... some of our immune proteins into the inflammatory defenders they ... appear in the June 8 issue of the Journal ... by a team of researchers in Italy, also suggests that ... into risk factors for intestinal disorders. Parasite-driven selection ...
... TEMPE, Ariz. The International Institute for Species Exploration ... taxonomists scientists responsible for species exploration and classification ... in 2008. On the list are a pea-sized ... The top 10 new species also include the very ...
Cached Biology News:Comprehensive cardiogenetic testing for families of sudden unexplained death victims can save lives 2Immune genes adapt to parasites 2Scientists announce top 10 new species; issue SOS 2Scientists announce top 10 new species; issue SOS 3Scientists announce top 10 new species; issue SOS 4Scientists announce top 10 new species; issue SOS 5
Peptide-affinity Purified Polyclonal Antibody to Prolactin Releasing Hormone Receptor (GPR10)...
... BalanceTalk XL provides balance data collection and ... Complete integration with Microsoft Excel , ... moisture analyzers , New balances can be added ... Collect data from multiple balances into one spreadsheet ...
Applications: Western blotting ...
...
Biology Products: